Cidara Therapeutics Inc. (CDTX) will host a Key Opinion Leader (KOL) meeting on its rezafungin and Cloudbreak programs on November 14, in New York City for institutional investors, sell-side analysts and business development professionals. Who are the KOLs? Neil J....